Literature DB >> 33505536

Correlation between Serum Bone Turnover Markers and Estimated Glomerular Filtration Rate in Chinese Patients with Diabetes.

Xuming Zhu1, Ying Zhou1, Shanchao Hong1, Yifeng Xue1, Yubao Cui1.   

Abstract

OBJECTIVE: Diabetes is a growing global public health concern with many significant disease complications. Multiple studies show that bone turnover markers (BTMs) are decreased in diabetes patients, indicating impaired bone metabolism in diabetes patients. A recent study also showed that in diabetes patients, BTMs are correlated with urine albumin to creatinine ratio, an indicator of nephropathy. However, whether BTMs are correlated with estimated glomerular filtration rate (eGFR) in diabetes remains unknown. This retrospective study accessed correlations between serum BTMs and eGFR in Chinese patients with diabetes and compare levels of BTMs and eGFR between diabetic patients and healthy individuals.
METHODS: This study analyzed data from 221 diabetic patients (include type1 and type 2 diabetes) and 155 healthy individuals. Serum BTM levels and eGFR were compared between diabetic patients and healthy individuals. Pearson correlation analysis was used to assess correlations between BTMs and eGFR. Multiple logistic regression analysis adjusted for gender and age was performed to measure odd ratio (OR) and 95% confidence interval (95% CI) of BTMs on diabetes.
RESULTS: Patients with diabetes had significant lower 25-hydroxyvitamin D (25(OH)D) levels (15.07 ± 6.20 ng/mL) than healthy group (17.89 ± 6.41 ng/mL) (P < 0.05). For patients with diabetes, eGFR was negatively correlated with osteocalcin (OC) (r = -0.434, P < 0.05), procollagen type 1 intact N-terminal propeptide (P1NP) (r = -0.350, P < 0.05), and β-carboxy-terminal cross-linking telopeptide of type I collagen (β-CTX) (r = -0.179, P < 0.05) levels. For healthy people, eGFR was negatively correlated with 25(OH)D (r = -0.290, P < 0.05) levels. Multiple logistic regression analysis adjusted for age and gender (mean age of diabetes was 64.9 years and the percentage of female was 66.9%, mean age of healthy people was 48.4 years and the percentage of female was 37.4%) showed that 25(OH)D (OR = 0.909, 95%CI = 0.862 - 0.959, P < 0.05) was protective factors for diabetes.
CONCLUSIONS: In the stage of diabetic nephropathy, bone turnover may accelerate. It is important to detect BTMs in the stage of diabetic nephropathy.
Copyright © 2021 Xuming Zhu et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33505536      PMCID: PMC7806398          DOI: 10.1155/2021/6731218

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  25 in total

1.  Associations of Bone Mineral Density and Bone Metabolism Indices with Urine Albumin to Creatinine Ratio in Chinese Patients with Type 2 Diabetes.

Authors:  Xin Zhao; Xiao-Mei Zhang; Ning Yuan; Xiao-Feng Yu; Li-Nong Ji
Journal:  Exp Clin Endocrinol Diabetes       Date:  2018-11-05       Impact factor: 2.949

Review 2.  MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis.

Authors:  Katrine Hygum; Jakob Starup-Linde; Torben Harsløf; Peter Vestergaard; Bente L Langdahl
Journal:  Eur J Endocrinol       Date:  2017-03       Impact factor: 6.664

3.  MicroRNAs 1915-3p, 2861, and 4532 Are Associated with Long-Term Renal Function Decline in Type 1 Diabetes.

Authors:  Maria Beatriz Monteiro; Daniele P Santos-Bezerra; Tatiana S Pelaes; Vishal S Vaidya; Maria Lucia Corrêa-Giannella
Journal:  Clin Chem       Date:  2019-08-19       Impact factor: 8.327

Review 4.  Diabetes Mellitus and Bone Metabolism.

Authors:  Christian Kasperk; Carmen Georgescu; Peter Nawroth
Journal:  Exp Clin Endocrinol Diabetes       Date:  2017-01-10       Impact factor: 2.949

Review 5.  Glomerular filtration rate equations: a comprehensive review.

Authors:  Carlos G Musso; Joaquín Álvarez-Gregori; José Jauregui; Juan F Macías-Núñez
Journal:  Int Urol Nephrol       Date:  2016-04-06       Impact factor: 2.370

6.  Diabetic Kidney Disease: Challenges, Progress, and Possibilities.

Authors:  Radica Z Alicic; Michele T Rooney; Katherine R Tuttle
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 8.237

7.  Association between osteocalcin and glucose metabolism: a meta-analysis.

Authors:  D-M Liu; X-Z Guo; H-J Tong; B Tao; L-H Sun; H-Y Zhao; G Ning; J-M Liu
Journal:  Osteoporos Int       Date:  2015-06-19       Impact factor: 4.507

8.  IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.

Authors:  K Ogurtsova; J D da Rocha Fernandes; Y Huang; U Linnenkamp; L Guariguata; N H Cho; D Cavan; J E Shaw; L E Makaroff
Journal:  Diabetes Res Clin Pract       Date:  2017-03-31       Impact factor: 5.602

Review 9.  Role of biochemical markers in the management of osteoporosis.

Authors:  K Henriksen; C Christiansen; M A Karsdal
Journal:  Climacteric       Date:  2015-10-27       Impact factor: 3.005

Review 10.  Osteoporosis, fractures, and diabetes.

Authors:  Peter Jackuliak; Juraj Payer
Journal:  Int J Endocrinol       Date:  2014-06-23       Impact factor: 3.257

View more
  1 in total

1.  Osteocalcin and Risks of Incident Diabetes and Diabetic Kidney Disease: A 4.6-Year Prospective Cohort Study.

Authors:  Xiaoqi Ye; Rong Yu; Fusong Jiang; Xuhong Hou; Li Wei; Yuqian Bao; Weiping Jia
Journal:  Diabetes Care       Date:  2022-04-01       Impact factor: 19.112

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.